AUGX - Augmedix, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-24,449
-24,449
-17,851
-15,604
-18,498
Depreciation & amortisation
-
856
691
867
949.006
Stock-based compensation
-
2,112
1,387
668.072
397.099
Change in working capital
-
2,212
-1,998
-1,020
1,234
Accounts receivable
-2,980
786
-4,431
-401.737
-126.2
Accounts payable
-
88
1,015
-396.863
373.747
Other working capital
-16,773
-16,773
-18,592
-15,046
-15,468
Other non-cash items
-
1,366
1,236
-54.272
1,204
Net cash provided by operating activities
-16,773
-16,773
-18,592
-14,399
-14,645
Cash flows from investing activities
Investments in property, plant and equipment
-
-1,408
-611
-647.015
-823.013
Net cash used for investing activities
-1,408
-1,408
-611
-647.015
-823.013
Cash flows from financing activities
Debt repayment
-
-16,125
-12,966
-
-1,358
Common stock issued
-
0
40,000
27,417
0
Dividends paid
-
-
-
0
0
Other financing activities
-
-142
-4,363
-3,761
-52.893
Net cash used provided by (used for) financing activities
-
-1,237
37,827
26,417
17,168
Net change in cash
-19,599
-19,599
18,614
11,370
1,689
Cash at beginning of period
3,429
41,587
22,973
11,603
9,914
Cash at end of period
11,121
21,988
41,587
22,973
11,603
Free cash flow
Operating cash flow
-16,773
-16,773
-18,592
-14,399
-14,645
Capital expenditure
-
-1,408
-611
-647.015
-823.013
Free cash flow
-16,773
-16,773
-18,592
-15,046
-15,468